MedWatch

ALK CEO sells shares for USD 1.5m

Carsten Hellmann, the chief executive of allergy firm ALK-Abelló, has sold company shares for almost DKK 11m (USD 1.5m).

Carsten Hellmann, CEO of ALK | Photo: ALK / PR

The chief executive of allergy firm ALK-Abelló, Carsten Hellmann, has sold shares in the firm for a total price close to DKK 11m (USD 1.5m), the ALK reports in a company release on Thursday.

The transaction entails 84,000 shares that were sold at an average price of DKK 128.66 (USD 18.3), equating to an aggregated price of DKK 10.8m.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs